SCHEMBL8685679

SCHEMBL8685679

O=Cc1c(Cc2ccc(F)cc2)[nH]c2ccccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 6/20 0.59
POLB P06746 1/20 0.54
LMNA P02545 2/20 0.44
MET P08581 1/20 0.40
CTSV O60911 1/20 0.40
CTSL P07711 1/20 0.40
ALDH1A1 P00352 2/20 0.40
HTT P42858 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KDM4E B2RXH2 2/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
GABRP O00591 1/20 0.39
GABRD O14764 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRB1 P18505 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6592979 0.87 AHR (0.66) AHRALDH1A1SMN1; SMN2KDM4EMEN1
SCHEMBL28003901 0.85 AHR (0.63) AHRPOLBLMNAMETALDH1A1
SCHEMBL9300229 0.85 AHR (0.59) AHRPOLBLMNACTSVCTSL
SCHEMBL28239180 0.78 AHR (0.52) AHRCTSVCTSLSMN1; SMN2MEN1
SCHEMBL28863000 0.77 AHR (0.54) AHRPOLBALDH1A1KDM4EMEN1
SCHEMBL2062029 0.76 PTGS2 (0.54) AHRPOLBCTSVCTSLKDM4E
SCHEMBL28804759 0.76 POLB (0.48) POLBLMNAMETCTSVCTSL
SCHEMBL1249895 0.76 AHR (0.59) AHRALDH1A1HTTMEN1KMT2A
SCHEMBL9274962 0.76 AHR (0.59) AHRPOLBLMNAALDH1A1HTT
SCHEMBL29951745 0.76 AHR (0.59) AHRALDH1A1HTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811439-A ANTIDIABETIC AGENTS; SIDE EFFECT REDUCTION; ANTILEPEMIC AGENTS SENGA PHARMACEUTICAL LABORATORY INC. (JP) 1998-09-22 US disclosed
EP-0780389-A1 Thiazolidinedione derivatives, process for their preparation and pharmaceutical compositions containing them TOBISHI PHARMACEUTICAL CO., LTD. (JP) 1997-06-25 EP disclosed